Pharmaceutical company, MeCure Industries PLC, (the Company) has announced the successful acquisition of a 𝟭𝟬% 𝗲𝗾𝘂𝗶𝘁𝘆 𝘀𝘁𝗮𝗸𝗲 in the company, by Zrosk Investment Management. The transaction, which was 𝗰𝗼𝗻𝗱𝘂𝗰𝘁𝗲𝗱 𝗼𝗳𝗳-𝗺𝗮𝗿𝗸𝗲𝘁, 𝘄𝗮𝘀 𝗳𝗶𝗻𝗮𝗹𝗶𝘇𝗲𝗱 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝗮𝗽𝗽𝗿𝗼𝘃𝗮𝗹 from the Nigerian Exchange Group (NGX Group). This strategic investment marks a significant milestone tor MeCure Industries as it continues to strengthen its capital base and accelerate its growth trajectory.
The share purchase 𝗺𝗮𝗸𝗲𝘀 𝗭𝗿𝗼𝘀𝗸 𝘁𝗵𝗲 𝗳𝗶𝗿𝘀𝘁 𝗶𝗻𝘀𝘁𝗶𝘁𝘂𝘁𝗶𝗼𝗻𝗮𝗹 𝗶𝗻𝘃𝗲𝘀𝘁𝗼𝗿 to take a significant stake in MeCure, where Mr Ubani held a 31.8 per cent interest and two other Indians – Samir Ubani and Avni Ubani – each held a 32.3 per cent stake before the transaction.
MeCure Industries Plc is a leading pharmaceutical company dedicated to producing high-quality medicines and healthcare products. Zrosk Investment Management is an African focused multi-asset investment management company with a strong commitment to catalyzing growth in underserved and underrepresented markets. Its portfolio comprises Max.ng, Ditto Africa, Union54, ZirooPay, Nord, Gartner Callaway, among others.
.png)
.jpg)
.jpeg)
